The Fibrin Patch Soft Tissue Study

Completed · Phase 2

Conditions studied: Hemostasis

In brief

The effectiveness objective of this study is to evaluate whether Fibrin Patch is superior to SURGICEL™ as an adjunct to achieving hemostasis during surgical procedures involving soft tissue bleeding in abdominal, pelvic, retroperitoneal and (non-cardiac) thoracic surgery.

Key facts

Study ID
NCT00658723
Run by
Ethicon, Inc.
People needed
141
Starts
2008-03-01
Expected to finish
2009-05-01
Last updated by the study team
2014-09-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.